Hospira to Present at Upcoming Investor Conferences
20 Maio 2009 - 4:30PM
PR Newswire (US)
LAKE FOREST, Ill., May 20 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a global specialty pharmaceutical and medication
delivery company, today announced that the company will present at
two upcoming conferences: -- Sanford C. Bernstein Twenty-Fifth
Annual Strategic Decisions Conference Thursday, May 28, 2009 - New
York City 3 p.m. Eastern time -- UBS Global Specialty
Pharmaceuticals Conference 2009 Wednesday, June 3, 2009 - London 10
a.m. Greenwich Mean Time / 4 a.m. Central time The presentations
will be available to all interested parties through live audiocasts
accessible via the investor relations section of Hospira's Web site
at http://www.hospirainvestor.com/. Listeners should log on
approximately 10 minutes in advance of each presentation to ensure
proper computer setup to receive the audiocast. The slides
accompanying the presentations will also be available on the
Hospira Web site. A replay of the webcast will be available on the
Hospira Web site approximately 24 hours after the live
presentations. About Hospira Hospira, Inc. is a global specialty
pharmaceutical and medication delivery company dedicated to
Advancing Wellness(TM). As the world leader in specialty generic
injectable pharmaceuticals, Hospira offers one of the broadest
portfolios of generic acute-care and oncology injectables, as well
as integrated infusion therapy and medication management solutions.
Through its products, Hospira helps improve the safety, cost and
productivity of patient care. The company is headquartered in Lake
Forest, Ill., and has more than 14,000 employees. Learn more at
http://www.hospira.com/.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Stacey Eisen, +1-224-212-2276, or Financial Community, Karen
King, +1-224-212-2711, both of Hospira, Inc. Web Site:
http://www.hospira.com/
Copyright